SCHEMBL6990082

SCHEMBL6990082

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(N(C)C)cc1)c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.41
TP53 P04637 5/20 0.41
LMNA P02545 7/20 0.40
KMT2A Q03164 5/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 3/20 0.38
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MCL1 Q07820 2/20 0.37
ESRRG P62508 1/20 0.36
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987871 0.90 CTSK (0.39) MAPTTP53LMNAKMT2ANPC1
SCHEMBL6986649 0.90 HTR1A (0.40) MAPTTP53LMNAKMT2ANPC1
SCHEMBL6988403 0.89 KMT2A (0.35) MAPTLMNAKMT2ANPC1HPGD
SCHEMBL6989542 0.88 TP53 (0.40) MAPTTP53LMNAALDH1A1ESRRG
SCHEMBL6990056 0.88 OPRM1 (0.37) LMNAALDH1A1POLB
SCHEMBL6988433 0.87 TAS1R3 (0.35) ESRRG
SCHEMBL6988694 0.85 ATM (0.39) MAPTTP53LMNAKMT2ANPC1
SCHEMBL6981853 0.84 TRPV1 (0.42) HDAC3HDAC1HDAC2
SCHEMBL6988884 0.83 CTSS (0.36) HPGDSMN1; SMN2ALDH1A1HDAC1
SCHEMBL6985501 0.82 GCGR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed